Osteomyelitis is a bacterial bone infection where Staphylococcus aureus builds an impenetrable biofilm fortress on necrotic bone, creating a chronic infection that antibiotics alone cannot cure. Understanding the difference between a sequestrum and involucrum, alongside the gold-standard Cierny-Mader classification, is essential for orthopaedic exams and surgical practice. Learn why radical debridement and the landmark OVIVA trial have revolutionised how we treat bone infections. β± Chapters 0:00 Intro 0:06 Bone Under Siege 0:18 The Sinusoidal Trap 0:32 The Biofilm Fortress 0:48 Death And Rebirth 1:02 MRI Reveals The Truth 1:19 Scalpel Meets Science 1:39 The OVIVA Revolution 1:53 Classify Debride Cure This video provides a comprehensive review of osteomyelitis pathophysiology, microbiology, and evidence-based management for orthopaedic examinations. It covers how sluggish sinusoidal blood flow and hairpin loops in the metaphysis trap bacteria, the critical role of the glycocalyx biofilm in antibiotic resistance, and why MRI is the imaging modality of choice with 90% sensitivity. We break down the Cierny-Mader classification, surgical indications, and the OVIVA trial which proved oral antibiotics are non-inferior to intravenous therapy for stable patients. 𦴠IN THIS VIDEO YOU'LL LEARN: β’ How biofilm formation on necrotic bone prevents antibiotic and neutrophil penetration β’ The difference between sequestrum, involucrum, and cloaca in chronic osteomyelitis β’ Why the metaphysis is the Achilles heel in children due to sluggish sinusoidal blood flow β’ How to apply the Cierny-Mader classification combining anatomic types with host status β’ Why MRI is the gold standard investigation showing marrow oedema within hours β’ Why CRP is superior to ESR for monitoring treatment response β’ The surgical indications for radical debridement and dead space management β’ How the OVIVA trial proved oral antibiotics are non-inferior to intravenous therapy β’ Matching causative organisms like Salmonella and Pseudomonas to specific clinical scenarios β±οΈ CHAPTERS: π KEY TAKEAWAYS: βοΈ Staphylococcus aureus causes 80% of osteomyelitis cases; biofilm makes it 1000x more resistant to antibiotics. βοΈ Chronic osteomyelitis requires surgical debridement of the sequestrum; antibiotics alone will fail. βοΈ CRP outruns ESR as your primary monitoring marker for treatment response. βοΈ MRI is the investigation of choice at 90% sensitivity, as plain X-rays take 10-14 days to show changes. βοΈ The OVIVA trial proved that oral antibiotics are non-inferior to IV therapy once a patient is clinically stable. βοΈ Do not base antibiotic choices on sinus tract swabs; deep intraoperative tissue culture is the gold standard. π©ββοΈ WHO THIS IS FOR: This video is designed for FRCS Trauma & Orthopaedic and FRACS exam candidates, medical students, junior doctors, and infectious disease trainees preparing for orthopaedic fellowship examinations. π RELATED TOPICS: Septic Arthritis in Children Β· Diabetic Foot Infection Management Β· Brodie's Abscess Β· Cierny-Mader Classification Β· OVIVA Trial Evidence Β· Periprosthetic Joint Infection π More free orthopaedic teaching at Orthovellum.com β subscribe for weekly videos. π¨ CREDITS: β’ Original Orthovellum production. β οΈ DISCLAIMER: Educational only β not individual medical advice. Always consult a qualified clinician for diagnosis and treatment. #osteomyelitis #orthopaedics #frcs #fracs #biofilm #sequestrum #involucrum #boneinfection #ciernymader #ovivatrial #medicalstudent #orthopaedicsurgery #staphylococcusaureus #diabeticfoot
27 Jul 2026